Picture of Achilles Therapeutics logo

ACHL — Achilles Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Achilles Therapeutics Reports Third Quarter Financial Results

Nov 8 (Reuters) - Achilles Therapeutics Plc  698Y.F :
    * ACHILLES THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
    * STRONG CASH BALANCE OF $179.9 MILLION SUPPORTS ALL PLANNED
OPERATIONS INTO Q2 2025
    * QTRLY LOSS PER SHARE $0.32
    * Q3 EARNINGS PER SHARE VIEW $-0.55 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7phH18 
Further company coverage:  698Y.F 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Achilles Therapeutics

See all news